Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
NAS:ZLTQ's Cash to Debt is ranked higher than
83% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. NAS:ZLTQ: No Debt )
Ranked among companies with meaningful Cash to Debt only.
NAS:ZLTQ' s Cash to Debt Range Over the Past 10 Years
Min: 6.45  Med: N/A Max: No Debt
Current: No Debt
Equity to Asset 0.62
NAS:ZLTQ's Equity to Asset is ranked lower than
52% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. NAS:ZLTQ: 0.62 )
Ranked among companies with meaningful Equity to Asset only.
NAS:ZLTQ' s Equity to Asset Range Over the Past 10 Years
Min: -5.35  Med: 0.69 Max: 0.89
Current: 0.62
-5.35
0.89
F-Score: 5
Z-Score: 15.63
M-Score: -1.29
WACC vs ROIC
10.47%
40.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -0.38
NAS:ZLTQ's Operating margin (%) is ranked lower than
55% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. NAS:ZLTQ: -0.38 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:ZLTQ' s Operating margin (%) Range Over the Past 10 Years
Min: -1082.23  Med: -17.33 Max: 1.45
Current: -0.38
-1082.23
1.45
Net-margin (%) 9.48
NAS:ZLTQ's Net-margin (%) is ranked higher than
75% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. NAS:ZLTQ: 9.48 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:ZLTQ' s Net-margin (%) Range Over the Past 10 Years
Min: -1111.78  Med: -17.29 Max: 16.37
Current: 9.48
-1111.78
16.37
ROE (%) 27.95
NAS:ZLTQ's ROE (%) is ranked higher than
92% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. NAS:ZLTQ: 27.95 )
Ranked among companies with meaningful ROE (%) only.
NAS:ZLTQ' s ROE (%) Range Over the Past 10 Years
Min: -299.73  Med: -28.57 Max: 42.91
Current: 27.95
-299.73
42.91
ROA (%) 17.93
NAS:ZLTQ's ROA (%) is ranked higher than
94% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. NAS:ZLTQ: 17.93 )
Ranked among companies with meaningful ROA (%) only.
NAS:ZLTQ' s ROA (%) Range Over the Past 10 Years
Min: -254.68  Med: -21.65 Max: 29.57
Current: 17.93
-254.68
29.57
ROC (Joel Greenblatt) (%) -5.13
NAS:ZLTQ's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 3.44 vs. NAS:ZLTQ: -5.13 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:ZLTQ' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1427.33  Med: -546.32 Max: 26.48
Current: -5.13
-1427.33
26.48
Revenue Growth (3Y)(%) 41.90
NAS:ZLTQ's Revenue Growth (3Y)(%) is ranked higher than
96% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. NAS:ZLTQ: 41.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:ZLTQ' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -68.6  Med: -27.95 Max: 41.9
Current: 41.9
-68.6
41.9
» NAS:ZLTQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

ZLTQ Guru Trades in Q4 2015

Paul Tudor Jones 13,600 sh (New)
Jim Simons 103,850 sh (New)
Steven Cohen 2,319,887 sh (+60.91%)
RS Investment Management 1,181,996 sh (-4.85%)
» More
Q1 2016

ZLTQ Guru Trades in Q1 2016

Columbia Wanger 726,246 sh (New)
Jim Simons 594,400 sh (+472.36%)
Paul Tudor Jones Sold Out
Steven Cohen 1,698,300 sh (-26.79%)
RS Investment Management 781,322 sh (-33.90%)
» More
Q2 2016

ZLTQ Guru Trades in Q2 2016

Chuck Royce 81,000 sh (New)
RS Investment Management 1,056,821 sh (+35.26%)
Steven Cohen 2,219,762 sh (+30.70%)
Columbia Wanger 533,203 sh (-26.58%)
Jim Simons 45,910 sh (-92.28%)
» More
Q3 2016

ZLTQ Guru Trades in Q3 2016

Paul Tudor Jones 5,947 sh (New)
Jim Simons 161,600 sh (+251.99%)
Chuck Royce 108,000 sh (+33.33%)
Columbia Wanger 412,602 sh (-22.62%)
Steven Cohen 797,696 sh (-64.06%)
» More
» Details

Insider Trades

Latest Guru Trades with ZLTQ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:NHNKY, NAS:BABY, NAS:INGN, NYSE:GMED, OTCPK:IOBCF, NAS:CNMD, NYSE:PEN, NAS:MDXG, NAS:CYNO, NAS:SPNC, NAS:VASC, NAS:WMGI, NYSE:NVRO, NYSE:ITGR, NAS:CSII, NAS:KTWO, NAS:OFIX, NYSE:CRY, NAS:GNMK, NAS:LIVN » details
ZELTIQ Aesthetics Inc is a medical technology company. The Company is engaged in developing and commercializing products utilizing its proprietary controlled cooling technology platform.

ZELTIQ Aesthetics Inc was incorporated in Delaware in March 2005 as Juniper Medical, Inc. In July 2007, it changed its name to ZELTIQ Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled cooling technology platform. Its first commercial product, the CoolSculpting system, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

Ratios

vs
industry
vs
history
P/E(ttm) 59.95
ZLTQ's P/E(ttm) is ranked lower than
79% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.16 vs. ZLTQ: 59.95 )
Ranked among companies with meaningful P/E(ttm) only.
ZLTQ' s P/E(ttm) Range Over the Past 10 Years
Min: 1.09  Med: 51.16 Max: 1724
Current: 59.95
1.09
1724
Forward P/E 78.13
ZLTQ's Forward P/E is ranked lower than
94% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 21.74 vs. ZLTQ: 78.13 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 59.95
ZLTQ's PE(NRI) is ranked lower than
79% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.53 vs. ZLTQ: 59.95 )
Ranked among companies with meaningful PE(NRI) only.
ZLTQ' s PE(NRI) Range Over the Past 10 Years
Min: 1.09  Med: 51.16 Max: 1724
Current: 59.95
1.09
1724
Price/Owner Earnings (ttm) 41.59
ZLTQ's Price/Owner Earnings (ttm) is ranked lower than
64% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 30.39 vs. ZLTQ: 41.59 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ZLTQ' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 25.75  Med: 40.14 Max: 3952.22
Current: 41.59
25.75
3952.22
P/B 14.52
ZLTQ's P/B is ranked lower than
95% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 3.08 vs. ZLTQ: 14.52 )
Ranked among companies with meaningful P/B only.
ZLTQ' s P/B Range Over the Past 10 Years
Min: 1.79  Med: 9.66 Max: 19.15
Current: 14.52
1.79
19.15
P/S 5.45
ZLTQ's P/S is ranked lower than
69% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.02 vs. ZLTQ: 5.45 )
Ranked among companies with meaningful P/S only.
ZLTQ' s P/S Range Over the Past 10 Years
Min: 0.16  Med: 4.27 Max: 7.94
Current: 5.45
0.16
7.94
PFCF 112.32
ZLTQ's PFCF is ranked lower than
93% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 26.13 vs. ZLTQ: 112.32 )
Ranked among companies with meaningful PFCF only.
ZLTQ' s PFCF Range Over the Past 10 Years
Min: 82.3  Med: 187.7 Max: 4204.44
Current: 112.32
82.3
4204.44
POCF 78.38
ZLTQ's POCF is ranked lower than
94% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 18.20 vs. ZLTQ: 78.38 )
Ranked among companies with meaningful POCF only.
ZLTQ' s POCF Range Over the Past 10 Years
Min: 58.67  Med: 131.29 Max: 245.71
Current: 78.38
58.67
245.71
EV-to-EBITDA 889.24
ZLTQ's EV-to-EBITDA is ranked lower than
99% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 16.23 vs. ZLTQ: 889.24 )
Ranked among companies with meaningful EV-to-EBITDA only.
ZLTQ' s EV-to-EBITDA Range Over the Past 10 Years
Min: -372.2  Med: -5.3 Max: 892.4
Current: 889.24
-372.2
892.4
Current Ratio 2.01
ZLTQ's Current Ratio is ranked lower than
63% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. ZLTQ: 2.01 )
Ranked among companies with meaningful Current Ratio only.
ZLTQ' s Current Ratio Range Over the Past 10 Years
Min: 1.09  Med: 2.7 Max: 8.23
Current: 2.01
1.09
8.23
Quick Ratio 1.57
ZLTQ's Quick Ratio is ranked lower than
55% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. ZLTQ: 1.57 )
Ranked among companies with meaningful Quick Ratio only.
ZLTQ' s Quick Ratio Range Over the Past 10 Years
Min: 0.78  Med: 2.17 Max: 7.85
Current: 1.57
0.78
7.85
Days Inventory 109.35
ZLTQ's Days Inventory is ranked higher than
62% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 134.83 vs. ZLTQ: 109.35 )
Ranked among companies with meaningful Days Inventory only.
ZLTQ' s Days Inventory Range Over the Past 10 Years
Min: 46.43  Med: 102.9 Max: 163.22
Current: 109.35
46.43
163.22
Days Sales Outstanding 44.99
ZLTQ's Days Sales Outstanding is ranked higher than
81% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. ZLTQ: 44.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
ZLTQ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.79  Med: 34.17 Max: 237.12
Current: 44.99
8.79
237.12
Days Payable 61.86
ZLTQ's Days Payable is ranked higher than
53% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. ZLTQ: 61.86 )
Ranked among companies with meaningful Days Payable only.
ZLTQ' s Days Payable Range Over the Past 10 Years
Min: 42.46  Med: 56.79 Max: 144.83
Current: 61.86
42.46
144.83

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -3.00
ZLTQ's 3-Year Average Share Buyback Ratio is ranked higher than
55% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. ZLTQ: -3.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ZLTQ' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -453  Med: -214.45 Max: -3
Current: -3
-453
-3

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 24.33
ZLTQ's Price/Net Current Asset Value is ranked lower than
87% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 6.51 vs. ZLTQ: 24.33 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ZLTQ' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.79  Med: 16.05 Max: 24.36
Current: 24.33
2.79
24.36
Price/Tangible Book 14.98
ZLTQ's Price/Tangible Book is ranked lower than
87% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 4.06 vs. ZLTQ: 14.98 )
Ranked among companies with meaningful Price/Tangible Book only.
ZLTQ' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.31  Med: 9.78 Max: 18.71
Current: 14.98
2.31
18.71
Price/Projected FCF 41.94
ZLTQ's Price/Projected FCF is ranked lower than
99% of the 124 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. ZLTQ: 41.94 )
Ranked among companies with meaningful Price/Projected FCF only.
ZLTQ' s Price/Projected FCF Range Over the Past 10 Years
Min: 37.35  Med: 101.22 Max: 407.57
Current: 41.94
37.35
407.57
Price/Median PS Value 1.27
ZLTQ's Price/Median PS Value is ranked lower than
68% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. ZLTQ: 1.27 )
Ranked among companies with meaningful Price/Median PS Value only.
ZLTQ' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.05  Med: 0.96 Max: 1.51
Current: 1.27
0.05
1.51
Price/Graham Number 6.29
ZLTQ's Price/Graham Number is ranked lower than
86% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 2.31 vs. ZLTQ: 6.29 )
Ranked among companies with meaningful Price/Graham Number only.
ZLTQ' s Price/Graham Number Range Over the Past 10 Years
Min: 0.42  Med: 4.92 Max: 32.08
Current: 6.29
0.42
32.08
Earnings Yield (Greenblatt) (%) -0.10
ZLTQ's Earnings Yield (Greenblatt) (%) is ranked lower than
53% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. ZLTQ: -0.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ZLTQ' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -0.1  Med: 0.4 Max: 299
Current: -0.1
-0.1
299

More Statistics

Revenue (TTM) (Mil) $327.3
EPS (TTM) $ 0.74
Beta1.08
Short Percentage of Float27.08%
52-Week Range $18.41 - 44.66
Shares Outstanding (Mil)39.98

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 351 411 481
EPS ($) -0.03 0.56 0.89
EPS w/o NRI ($) -0.03 0.56 0.89
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:ZLTQ

Headlines

Articles On GuruFocus.com
Steven Cohen's Newest Buys, Additions and Reductions Mar 04 2015 
Steven Cohen Buys New Drug Stock, Triples Investment in Medical Company Jan 25 2015 
4 Stocks To Buy, 1 To Avoid In 2012 Feb 18 2012 
Weekly CFO Sales Highlight: INFA, DHR, AN, SMTC, ZLTQ Oct 31 2011 

More From Other Websites
Dow up more than 300 points Dec 07 2016
ZELTIQ Is The Leader In Non-Invasive Fat Reduction, Says Aegis Dec 07 2016
Coverage initiated on ZELTIQ Aesthetics by Aegis Capital Dec 07 2016
Is Schweitzer-Mauduit International, Inc. (SWM) A Good Stock To Buy? Dec 05 2016
Is Zeltiq Aesthetics Inc (ZLTQ) A Good Stock To Buy? Nov 30 2016
ETFs with exposure to ZELTIQ Aesthetics, Inc. : November 18, 2016 Nov 18 2016
ZELTIQ AESTHETICS INC Financials Nov 17 2016
ZELTIQ Aesthetics, Inc. :ZLTQ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 16, 2016 Nov 16 2016
New Strong Buy Stocks for November 10th Nov 10 2016
Edited Transcript of ZLTQ earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 10 2016
Zeltiq tops Street 3Q forecasts Nov 09 2016
Zeltiq tops Street 3Q forecasts Nov 09 2016
ZELTIQ Announces Third Quarter 2016 Financial Results Nov 09 2016
ZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 09 2016
ZELTIQ Announces Third Quarter 2016 Financial Results Nov 09 2016
Q3 2016 ZELTIQ Aesthetics Inc Earnings Release - After Market Close Nov 09 2016
Medical Product Q3 Earnings on Nov 9: ICUI, EGRX & More Nov 08 2016
ZELTIQ Aesthetics, Inc. to Present at Investor Conferences in November 2016 Nov 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)